1600 participants
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-21
- Start Date:
- 2026-11-30
- Completion:
- 2032-09-03
Conditions
- Alzheimer's Disease
Interventions
- DRUG
No Results Yet